Capital International Investors Abbott Laboratories Transaction History
Capital International Investors
- $504 Billion
- Q3 2024
A detailed history of Capital International Investors transactions in Abbott Laboratories stock. As of the latest transaction made, Capital International Investors holds 65,743,927 shares of ABT stock, worth $7.52 Billion. This represents 1.49% of its overall portfolio holdings.
Number of Shares
65,743,927
Previous 71,799,826
8.43%
Holding current value
$7.52 Billion
Previous $7.46 Billion
0.47%
% of portfolio
1.49%
Previous 1.57%
Shares
28 transactions
Others Institutions Holding ABT
# of Institutions
3,186Shares Held
1.3BCall Options Held
8.74MPut Options Held
8.08M-
Vanguard Group Inc Valley Forge, PA168MShares$19.2 Billion0.35% of portfolio
-
Black Rock Inc. New York, NY131MShares$15 Billion0.31% of portfolio
-
State Street Corp Boston, MA76.7MShares$8.77 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA53.3MShares$6.09 Billion1.31% of portfolio
-
Geode Capital Management, LLC Boston, MA34.9MShares$3.99 Billion0.33% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $200B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...